A novel pyrosequencing assay for the detection of neuraminidase inhibitor resistance-conferring mutations among clinical isolates of avian H7N9 influenza virus
Yuhua Qi(Southeast University), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Yan Li(Public Health Agency of Canada), Hua Wang(Chinese Center For Disease Control and Prevention), Huan Fan(Jiangsu Provincial Center for Disease Control and Prevention), Xian Qi(Peking University), Zheng Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Tao Wu, Minghao Zhou(Jiangsu Provincial Center for Disease Control and Prevention), Zhiyang Shi, Kangchen Zhao(Jiangsu Provincial Center for Disease Control and Prevention), Xiling Guo(Jiangsu Provincial Center for Disease Control and Prevention), Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Yunfeng Shan(Chinese Center For Disease Control and Prevention), Yin Chen(Jiangsu Provincial Center for Disease Control and Prevention)
Cited by 19
Related Papers
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season
|Clinical Infectious Diseases|2016|232
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204